Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A population-based study of IL4 polymorphisms in multiple sclerosis.

Orhun H Kantarci1, Janet L Schaefer-Klein, David D Hebrink

  • 1Department of Neurology, Mayo Clinic and Foundation, 200 First Street, SW, Rochester, MN 55905, USA.

Journal of Neuroimmunology
|April 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunity Gone Viral: Subacute Cognitive Decline With Multifocal Brain Lesions in Neuromyelitis Optica Spectrum Disorder.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Double strand breaks drive toxicity in a Huntington's disease mouse model with or without somatic expansion.

Nature communications·2026
Same author

Identification of genetic risk loci associated with aquaporin 4-positive neuromyelitis optica spectrum disorder: a genome-wide association study.

The Lancet. Neurology·2026
Same author

Critical demyelinating lesions in progressive multiple sclerosis: a prospective observational study.

Journal of neurology·2025
Same author

Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.

Neurology(R) neuroimmunology & neuroinflammation·2025
Same author

Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.

Neurology(R) neuroimmunology & neuroinflammation·2025

Interleukin-4 gene (IL4) polymorphisms are linked to multiple sclerosis (MS) susceptibility. Specific IL4 gene variants, particularly I3(709)*VNTR, show association with increased MS risk in sporadic cases.

Area of Science:

  • Genetics
  • Immunology
  • Neuroscience

Background:

  • Previous research suggests the interleukin-4 gene (IL4) plays a role in autoimmune diseases, including multiple sclerosis (MS).
  • Understanding genetic susceptibility factors for MS is crucial for developing targeted prevention and treatment strategies.

Purpose of the Study:

  • To investigate the association between novel and established polymorphisms in the IL4 gene and susceptibility to, age of onset, and disease course/severity in sporadic multiple sclerosis (MS) cases.
  • To identify specific IL4 gene variants that may confer risk or influence the clinical presentation of MS.

Main Methods:

  • Screening of the IL4 gene's promoter region, exons 1-4, and splice sites for polymorphisms.
  • Association testing of novel polymorphisms (E1(33)*C-->T, I3(2580)*C-->A) and established polymorphisms (5'(-523)*C-->T, I3(709)*VNTR) with MS characteristics in sporadic cases.

Related Experiment Videos

  • Statistical analysis including odds ratios (OR) and confidence intervals (CI) to evaluate genetic associations.

    • Main Results:

    • The I3(709)*VNTR polymorphism was significantly associated with MS susceptibility (p=0.004), primarily due to a lower frequency of heterozygotes in patients compared to controls.
    • Homozygosity for the uncommon I3(709)*allele-2 and carriage of specific extended haplotypes (e.g., 5'(-523)*T/E1(33)*T/I3(709)*allele-2/I3(2580)*C) showed a trend towards increased MS susceptibility.
    • No significant association was found between I3(709)*allele-2 carriage and older age of onset, although a trend suggested a link between homozygosity for this allele and later onset.

    Conclusions:

    • Specific polymorphisms within the Interleukin-4 gene, particularly I3(709)*VNTR, are associated with susceptibility to multiple sclerosis in sporadic cases.
    • Certain extended haplotypes involving IL4 gene variants may also contribute to MS risk.
    • Further research is needed to elucidate the precise mechanisms by which IL4 gene variations influence MS pathogenesis and clinical course.